arrow_back Back Filing freshness 10-Q Q1 FY2027 SEC EDGAR

download Export Data

HeartSciences Inc.

HSCS

$4.57 ▼ -0.01 (-0.33%) at close

22 Visible periods

26 Metrics

Absolute Benchmarks

Price Chart

Health

Weak

Bearish Absolute basis

auto_awesome

Analytical Summary

On an absolute basis, HeartSciences Inc. shows weak fundamentals, weighed down by Return on Invested Capital and FCF / Net Income. These readings use fixed quality thresholds rather than peer benchmarks, because too few comparable companies are available to rank against.

Market Cap $16.8M

Dividend Yield —

Revenue Growth 10.5%

Op. Margin —

ROIC 114.2% ↗

FCF / Share $-0.36

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Sep 23, 2026.

22-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$2.10K

↑ +10.5% —

Net Income Profit after all expenses

$-3.17M

↓ -54.4% —

FCF / Share Free cash flow per share

$-0.36

↑ +76.0% —

info Signals below are graded against fixed quality thresholds, not peers — peer ranking needs more comparable companies.

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Invested CapitalReturn on Invested Capital of -3239.3% is weak on an absolute basis (target > 10%)
FCF / Net IncomeFCF / Net Income of 0.81x is caution on an absolute basis (target > 1x)

Health Breakdown

Cash Quality ↑

Dividend History

Dividend / share · sourced from SEC filings

$0.00 Latest / share

FY 2021

FY 2022

FY 2023

FY 2024

FY 2025

$0.00

FY 2026

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	Q1 FY2027 Jul 31, 2026 10-Q ↗	Q4 FY2026 Apr 30, 2026 10-K ↗	Q3 FY2026 Jan 31, 2026 10-Q ↗	Q2 FY2026 Oct 31, 2025 10-Q ↗	Q1 FY2026 Jul 31, 2025 10-Q ↗	Q4 FY2025 Apr 30, 2025 10-K ↗	Q3 FY2025 Apr 30, 2025 10-Q ↗	Q2 FY2025 Oct 31, 2024 10-Q ↗	Q1 FY2025 Jul 31, 2024 10-Q ↗	Q4 FY2024 Apr 30, 2024 10-K ↗	Q3 FY2024 Jan 31, 2024 10-Q ↗	Q2 FY2024 Oct 31, 2023 10-Q ↗	Q1 FY2024 Jul 31, 2023 10-Q ↗	Q4 FY2023 Apr 30, 2023 10-K ↗	Q3 FY2023 Jan 31, 2023 10-Q ↗	Q2 FY2023 Oct 31, 2022 10-Q ↗	Q1 FY2023 Jul 31, 2022 10-Q ↗	Q4 FY2022 Apr 30, 2022 10-K ↗	Q3 FY2022 Jan 31, 2022 10-Q ↗	Q2 FY2022 Oct 31, 2021 10-Q ↗	Q1 FY2022 Jul 31, 2021 10-Q ↗	Q4 FY2021 Apr 30, 2021 10-K ↗
Revenue Growth YoY (%)	10.5% Good Good Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+32%)	N/M	—	—	—	—	N/M	—	—	—	653.8% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+8073%)	—	—	N/M	-28.8% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-460%)	—	-57.2% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-816%)	—	—	—	—	—
EPS Growth YoY (%)	45.6% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	53.7% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	75.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	62.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	40.2% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	N/M	14.3% Fair ↓ Fair Declining Year-over-year change in earnings per share Optimal: > 10%	85.8% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	79.7% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	N/M	81.2% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	27.3% Excellent → Excellent Stable Year-over-year change in earnings per share Optimal: > 10%	53.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-30.1% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	56.8% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	29.0% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	-86.7% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—
Net Income Growth YoY (%)	-54.4% Weak ↓ Weak Declining Year-over-year change in net income	-31.4% Weak ↓ Weak Declining Year-over-year change in net income	21.7% Good ↑ Good Improving Year-over-year change in net income	-12.9% Weak ↑ Weak Improving Year-over-year change in net income	-0.2% Weak ↑ Weak Improving Year-over-year change in net income	-13.4% Weak ↑ Weak Improving Year-over-year change in net income	-54.3% Weak ↓ Weak Declining Year-over-year change in net income	-19.1% Weak ↑ Weak Improving Year-over-year change in net income	-50.1% Weak ↓ Weak Declining Year-over-year change in net income	-13.1% Weak ↓ Weak Declining Year-over-year change in net income	-22.5% Weak ↓ Weak Declining Year-over-year change in net income	3.2% Caution ↓ Caution Declining Year-over-year change in net income	13.1% Fair ↑ Fair Improving Year-over-year change in net income	20.5% Good ↑ Good Improving Year-over-year change in net income	-8.4% Weak ↑ Weak Improving Year-over-year change in net income	-74.6% Weak Weak Year-over-year change in net income	-213.5% Weak Weak Year-over-year change in net income	—	—	—	—	—
FCF Growth YoY (%)	76.0% Excellent Excellent Year-over-year change in free cash flow	—	71.7% Excellent Excellent Year-over-year change in free cash flow	—	42.3% Excellent Excellent Year-over-year change in free cash flow	—	—	—	81.0% Excellent Excellent Year-over-year change in free cash flow	—	—	—	57.7% Excellent Excellent Year-over-year change in free cash flow	—	—	—	-48.8% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—
Revenue CAGR 3Y (%)	—	—	—	—	-16.0% Weak Weak Compound annual revenue growth over 3 years	1.6% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 5Y (%)	-22.4% Weak Weak Compound annual revenue growth over 5 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 1 metrics

Metric	Q1 FY2027 Jul 31, 2026 10-Q ↗	Q4 FY2026 Apr 30, 2026 10-K ↗	Q3 FY2026 Jan 31, 2026 10-Q ↗	Q2 FY2026 Oct 31, 2025 10-Q ↗	Q1 FY2026 Jul 31, 2025 10-Q ↗	Q4 FY2025 Apr 30, 2025 10-K ↗	Q3 FY2025 Apr 30, 2025 10-Q ↗	Q2 FY2025 Oct 31, 2024 10-Q ↗	Q1 FY2025 Jul 31, 2024 10-Q ↗	Q4 FY2024 Apr 30, 2024 10-K ↗	Q3 FY2024 Jan 31, 2024 10-Q ↗	Q2 FY2024 Oct 31, 2023 10-Q ↗	Q1 FY2024 Jul 31, 2023 10-Q ↗	Q4 FY2023 Apr 30, 2023 10-K ↗	Q3 FY2023 Jan 31, 2023 10-Q ↗	Q2 FY2023 Oct 31, 2022 10-Q ↗	Q1 FY2023 Jul 31, 2022 10-Q ↗	Q4 FY2022 Apr 30, 2022 10-K ↗	Q3 FY2022 Jan 31, 2022 10-Q ↗	Q2 FY2022 Oct 31, 2021 10-Q ↗	Q1 FY2022 Jul 31, 2021 10-Q ↗	Q4 FY2021 Apr 30, 2021 10-K ↗
FCF / Net Income (x)	0.42x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.61x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.74x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.99x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.95x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.76x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.64x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	—	0.98x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.88x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	1.03x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	1.15x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	—	1.16x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.58x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.78x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.74x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	1.43x Good Good Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2027 Jul 31, 2026 10-Q ↗	Q4 FY2026 Apr 30, 2026 10-K ↗	Q3 FY2026 Jan 31, 2026 10-Q ↗	Q2 FY2026 Oct 31, 2025 10-Q ↗	Q1 FY2026 Jul 31, 2025 10-Q ↗	Q4 FY2025 Apr 30, 2025 10-K ↗	Q3 FY2025 Apr 30, 2025 10-Q ↗	Q2 FY2025 Oct 31, 2024 10-Q ↗	Q1 FY2025 Jul 31, 2024 10-Q ↗	Q4 FY2024 Apr 30, 2024 10-K ↗	Q3 FY2024 Jan 31, 2024 10-Q ↗	Q2 FY2024 Oct 31, 2023 10-Q ↗	Q1 FY2024 Jul 31, 2023 10-Q ↗	Q4 FY2023 Apr 30, 2023 10-K ↗	Q3 FY2023 Jan 31, 2023 10-Q ↗	Q2 FY2023 Oct 31, 2022 10-Q ↗	Q1 FY2023 Jul 31, 2022 10-Q ↗	Q4 FY2022 Apr 30, 2022 10-K ↗	Q3 FY2022 Jan 31, 2022 10-Q ↗	Q2 FY2022 Oct 31, 2021 10-Q ↗	Q1 FY2022 Jul 31, 2021 10-Q ↗	Q4 FY2021 Apr 30, 2021 10-K ↗
Return on Invested Capital (%)	114.2% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-976.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-57.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-39.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-47.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-739.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-104.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-39.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-27.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-20.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-14.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	75.2% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	202.3% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-547.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	401.0% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-129.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-39.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	25.8% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	21.2% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	22.0% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	27.9% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-78.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-60.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-25.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-34.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	-29.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-25.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-25.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-19.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-14.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-66.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-51.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-48.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-37.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-37.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-25.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	-94.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—
Return on Common Equity (%) (%)	156.0% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+940%)	—	-74.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-599%)	-56.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-475%)	-65.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-536%)	—	-142.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1046%)	-51.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-446%)	-34.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-331%)	-25.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-268%)	-19.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-227%)	106.0% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+607%)	263.0% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1653%)	—	—	-166.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1212%)	-54.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-463%)	33.9% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+126%)	30.2% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+101%)	30.1% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+100%)	26.3% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+75%)	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	Q1 FY2027 Jul 31, 2026 10-Q ↗	Q4 FY2026 Apr 30, 2026 10-K ↗	Q3 FY2026 Jan 31, 2026 10-Q ↗	Q2 FY2026 Oct 31, 2025 10-Q ↗	Q1 FY2026 Jul 31, 2025 10-Q ↗	Q4 FY2025 Apr 30, 2025 10-K ↗	Q3 FY2025 Apr 30, 2025 10-Q ↗	Q2 FY2025 Oct 31, 2024 10-Q ↗	Q1 FY2025 Jul 31, 2024 10-Q ↗	Q4 FY2024 Apr 30, 2024 10-K ↗	Q3 FY2024 Jan 31, 2024 10-Q ↗	Q2 FY2024 Oct 31, 2023 10-Q ↗	Q1 FY2024 Jul 31, 2023 10-Q ↗	Q4 FY2023 Apr 30, 2023 10-K ↗	Q3 FY2023 Jan 31, 2023 10-Q ↗	Q2 FY2023 Oct 31, 2022 10-Q ↗	Q1 FY2023 Jul 31, 2022 10-Q ↗	Q4 FY2022 Apr 30, 2022 10-K ↗	Q3 FY2022 Jan 31, 2022 10-Q ↗	Q2 FY2022 Oct 31, 2021 10-Q ↗	Q1 FY2022 Jul 31, 2021 10-Q ↗	Q4 FY2021 Apr 30, 2021 10-K ↗
Interest Coverage (x)	—	—	—	—	—	—	—	—	—	—	-12.88x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-8.80x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-36.70x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-47.08x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-39.91x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-54.10x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-9.96x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-25.67x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-7.91x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-12.28x Weak Weak Operating income divided by interest expense Optimal: > 5x	-8.69x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-29.91K	$-1.10M	$-3.40M	$-1.95M	$-2.79M	$-1.10M	—	$-4.05M	$-4.34M	$-5.81M	$-7.08M	$-100.14K	$-575.65K	$-1.66M	$-1.93M	$-3.08M	$-4.27M	$-918.26K	—	—	—	—

📊 What does each share earn? 8 metrics

Metric	Q1 FY2027 Jul 31, 2026 10-Q ↗	Q4 FY2026 Apr 30, 2026 10-K ↗	Q3 FY2026 Jan 31, 2026 10-Q ↗	Q2 FY2026 Oct 31, 2025 10-Q ↗	Q1 FY2026 Jul 31, 2025 10-Q ↗	Q4 FY2025 Apr 30, 2025 10-K ↗	Q3 FY2025 Apr 30, 2025 10-Q ↗	Q2 FY2025 Oct 31, 2024 10-Q ↗	Q1 FY2025 Jul 31, 2024 10-Q ↗	Q4 FY2024 Apr 30, 2024 10-K ↗	Q3 FY2024 Jan 31, 2024 10-Q ↗	Q2 FY2024 Oct 31, 2023 10-Q ↗	Q1 FY2024 Jul 31, 2023 10-Q ↗	Q4 FY2023 Apr 30, 2023 10-K ↗	Q3 FY2023 Jan 31, 2023 10-Q ↗	Q2 FY2023 Oct 31, 2022 10-Q ↗	Q1 FY2023 Jul 31, 2022 10-Q ↗	Q4 FY2022 Apr 30, 2022 10-K ↗	Q3 FY2022 Jan 31, 2022 10-Q ↗	Q2 FY2022 Oct 31, 2021 10-Q ↗	Q1 FY2022 Jul 31, 2021 10-Q ↗	Q4 FY2021 Apr 30, 2021 10-K ↗
Revenue per Share (USD)	$0.00	—	$0.00	$0.00	$0.00	—	$0.00	—	—	—	$0.03	$0.04	—	—	$0.02	—	$0.06	—	$0.08	$0.00	$0.23	—
Basic EPS, GAAP (USD)	$-0.86	$-0.87	$-0.63	$-0.85	$-1.58	$-1.88	$-2.57	$-2.27	$-2.64	$0.11	$-3.00	$-16.00	$-13.00	$-79.36	$-16.00	$-22.00	$-28.00	$-61.00	$-37.00	$-31.00	$-15.00	—
Free Cash Flow per Share (USD)	$-0.36	—	$-0.47	$-0.84	$-1.50	—	$-1.64	—	$-2.60	—	—	—	$-13.64	—	—	—	$-32.22	—	$-29.07	$-23.18	$-21.65	—
Dividend per Share (USD)	$0.00	$0.00	—	—	—	$0.00	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$-0.52	$0.18	$0.83	$1.36	$1.38	—	$1.81	$4.24	$6.55	$10.81	$13.57	$-14.71	$-4.87	$2.28	$-3.09	$13.19	$35.32	$-182.19	$-123.42	$-103.87	$-57.62	—
Tangible Book Value per Share (USD)	$-0.52	$0.18	$0.31	$1.36	$1.38	—	$1.81	$4.24	$6.55	$10.81	$13.57	$-14.71	$-4.87	$2.28	$-3.09	$13.19	$35.32	$-182.19	$-123.42	$-103.87	$-57.62	—
Basic Weighted Avg Shares (shares)	3.67M	—	3.16M	2.78M	1.30M	—	986,057	917,445	777,746	—	537,927	109,389	103,315	—	82,408	82,105	56,452	—	33,235	33,138	33,138	—
Dividend Payout Ratio (%)	0.0% Excellent Excellent Dividends paid as a percentage of earnings Optimal: 30-60%	0.0% Excellent Excellent Dividends paid as a percentage of earnings Optimal: 30-60%	—	—	—	0.0% Excellent Excellent Dividends paid as a percentage of earnings Optimal: 30-60%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q1 FY2027 Jul 31, 2026 10-Q ↗	Q4 FY2026 Apr 30, 2026 10-K ↗	Q3 FY2026 Jan 31, 2026 10-Q ↗	Q2 FY2026 Oct 31, 2025 10-Q ↗	Q1 FY2026 Jul 31, 2025 10-Q ↗	Q4 FY2025 Apr 30, 2025 10-K ↗	Q3 FY2025 Apr 30, 2025 10-Q ↗	Q2 FY2025 Oct 31, 2024 10-Q ↗	Q1 FY2025 Jul 31, 2024 10-Q ↗	Q4 FY2024 Apr 30, 2024 10-K ↗	Q3 FY2024 Jan 31, 2024 10-Q ↗	Q2 FY2024 Oct 31, 2023 10-Q ↗	Q1 FY2024 Jul 31, 2023 10-Q ↗	Q4 FY2023 Apr 30, 2023 10-K ↗	Q3 FY2023 Jan 31, 2023 10-Q ↗	Q2 FY2023 Oct 31, 2022 10-Q ↗	Q1 FY2023 Jul 31, 2022 10-Q ↗	Q4 FY2022 Apr 30, 2022 10-K ↗	Q3 FY2022 Jan 31, 2022 10-Q ↗	Q2 FY2022 Oct 31, 2021 10-Q ↗	Q1 FY2022 Jul 31, 2021 10-Q ↗	Q4 FY2021 Apr 30, 2021 10-K ↗
Working Capital (USD)	$-4.82M	$-1.53M	$829.92K	$2.23M	$1.40M	—	—	$2.39M	$4.72M	$5.60M	$6.98M	$-1.72M	$131.31K	$863.69K	$885.00K	$988.20K	$3.89M	$-1.54M	—	—	—	—
Total Equity (USD)	$-2.03M	$205.17K	$2.65M	$4.18M	$3.14M	$205.17K	$1.79M	$4.02M	$5.93M	$7.32M	$8.63M	$-1.65M	$-519.70K	$230.56K	$-257.91K	$1.08M	$2.89M	$-6.06M	$-4.10M	$-3.44M	$-1.91M	$-1.91M

📋 What is driving earnings? 4 metrics

Metric	Q1 FY2027 Jul 31, 2026 10-Q ↗	Q4 FY2026 Apr 30, 2026 10-K ↗	Q3 FY2026 Jan 31, 2026 10-Q ↗	Q2 FY2026 Oct 31, 2025 10-Q ↗	Q1 FY2026 Jul 31, 2025 10-Q ↗	Q4 FY2025 Apr 30, 2025 10-K ↗	Q3 FY2025 Apr 30, 2025 10-Q ↗	Q2 FY2025 Oct 31, 2024 10-Q ↗	Q1 FY2025 Jul 31, 2024 10-Q ↗	Q4 FY2024 Apr 30, 2024 10-K ↗	Q3 FY2024 Jan 31, 2024 10-Q ↗	Q2 FY2024 Oct 31, 2023 10-Q ↗	Q1 FY2024 Jul 31, 2023 10-Q ↗	Q4 FY2023 Apr 30, 2023 10-K ↗	Q3 FY2023 Jan 31, 2023 10-Q ↗	Q2 FY2023 Oct 31, 2022 10-Q ↗	Q1 FY2023 Jul 31, 2022 10-Q ↗	Q4 FY2022 Apr 30, 2022 10-K ↗	Q3 FY2022 Jan 31, 2022 10-Q ↗	Q2 FY2022 Oct 31, 2021 10-Q ↗	Q1 FY2022 Jul 31, 2021 10-Q ↗	Q4 FY2021 Apr 30, 2021 10-K ↗
Sales/Revenue/Turnover (USD)	$2.10K	$0.00	$0.00	$2.42K	$1.90K	$4.35K	$0.00	—	—	$0.00	$14.70K	$3.90K	—	$0.00	$1.95K	—	$3.20K	$4.15K	$2.74K	$0.00	$7.48K	—
Depreciation Expense (USD)	$6.33K	$6.76K	$6.92K	$7.01K	$7.11K	$7.51K	$6.01K	—	$11.86K	$9.20K	—	—	$7.34K	$6.83K	—	—	$6.41K	$6.50K	$6.50K	$6.60K	$6.97K	—
Net Income, GAAP (USD)	$-3.17M	$-2.75M	$-1.99M	$-2.35M	$-2.05M	$-2.09M	$-2.54M	$-2.08M	$-2.05M	$-1.85M	$-1.64M	$-1.75M	$-1.37M	$-1.63M	$-1.34M	$-1.81M	$-1.57M	$-2.05M	$-1.24M	$-1.03M	$-501.85K	—
Operating Cash Flow (USD)	$-1.32M	$-1.68M	$-1.46M	$-2.33M	$-1.95M	$-1.59M	$-1.62M	—	$-2.02M	$-1.58M	—	—	$-1.40M	$-1.86M	—	—	$-1.81M	$-1.19M	$-966.28K	$-768.05K	$-717.49K	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 6 years · 22 quarters

HeartSciences Inc.

Analytical Summary

22-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Dividend History

Statement lens

Benchmark Lens

Benchmarks unavailable

Compare HSCS with peers